HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia.

AbstractBACKGROUND:
Endoscopic ablation to treat Barrett's esophagus (BE) with high-grade dysplasia (HGD) is associated with a decreased incidence of esophageal adenocarcinoma. Endoscopic spray cryotherapy (CRYO) demonstrates promising preliminary data.
OBJECTIVE:
To assess the safety and efficacy of CRYO in BE with HGD.
DESIGN:
Multicenter, retrospective cohort study.
SETTING:
Nine academic and community centers; treatment period, 2007 to 2009.
PATIENTS:
Subjects with HGD confirmed by 2 pathologists. Previous EMR was allowed if residual HGD remained.
INTERVENTIONS:
CRYO with follow-up biopsies.
MAIN OUTCOME MEASUREMENTS:
Complete eradication of HGD with persistent low-grade dysplasia, complete eradication of all dysplasia with persistent nondysplastic intestinal metaplasia, and complete eradication of all intestinal metaplasia.
RESULTS:
Ninety-eight subjects (mean age 65.4 years, 83% male) with BE and HGD (mean length 5.3 cm) underwent 333 treatments (mean 3.4 treatments per subject). There were no esophageal perforations. Strictures developed in 3 subjects. Two subjects reported severe chest pain managed with oral narcotics. One subject was hospitalized for bright red blood per rectum. Sixty subjects had completed all planned CRYO treatments and were included in the efficacy analysis. Fifty-eight subjects (97%) had complete eradication of HGD, 52 (87%) had complete eradication of all dysplasia with persistent nondysplastic intestinal metaplasia, and 34 (57%) had complete eradication of all intestinal metaplasia. Subsquamous BE was found in 2 subjects (3%).
LIMITATIONS:
Nonrandomized, retrospective study with no control group, short follow-up (10.5 months), lack of centralized pathology, and use of surrogate outcome for decreased cancer risk.
CONCLUSIONS:
CRYO is a safe and well-tolerated therapy for BE and HGD. Short-term results suggest that CRYO is highly effective in eradicating HGD.
AuthorsNicholas J Shaheen, Bruce D Greenwald, Anne F Peery, John A Dumot, Norman S Nishioka, Herbert C Wolfsen, J Steven Burdick, Julian A Abrams, Kenneth K Wang, Damien Mallat, Mark H Johnston, Alvin M Zfass, Jenny O Smith, James S Barthel, Charles J Lightdale
JournalGastrointestinal endoscopy (Gastrointest Endosc) Vol. 71 Issue 4 Pg. 680-5 (Apr 2010) ISSN: 1097-6779 [Electronic] United States
PMID20363409 (Publication Type: Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2010 American Society for Gastrointestinal Endoscopy. Published by Mosby, Inc. All rights reserved.
Chemical References
  • Aerosols
Topics
  • Aerosols
  • Aged
  • Barrett Esophagus (diagnosis, pathology, surgery)
  • Biopsy
  • Chest Pain (etiology)
  • Cohort Studies
  • Cryosurgery (methods)
  • Esophageal Neoplasms (diagnosis, pathology, surgery)
  • Esophageal Stenosis (etiology)
  • Esophagoscopy
  • Esophagus (pathology, surgery)
  • Female
  • Follow-Up Studies
  • Gastrointestinal Hemorrhage (etiology)
  • Humans
  • Male
  • Middle Aged
  • Postoperative Complications (etiology)
  • Precancerous Conditions (diagnosis, pathology, surgery)
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: